Literature DB >> 17635857

Prostaglandin E2 induces vascular relaxation by E-prostanoid 4 receptor-mediated activation of endothelial nitric oxide synthase.

Ana-Marija Hristovska1, Lasse E Rasmussen, Pernille B L Hansen, Susan S Nielsen, Rolf M Nüsing, Shuh Narumiya, Paul Vanhoutte, Ole Skøtt, Boye L Jensen.   

Abstract

The present experiments were designed to test the hypothesis that prostaglandin (PG) E(2) causes vasodilatation through activation of endothelial NO synthase (eNOS). Aortic rings from mice with targeted deletion of eNOS and E-prostanoid (EP) receptors were used for contraction studies. Blood pressure changes in response to PGE(2) were measured in conscious mice. Single doses of PGE(2) caused concentration-dependent relaxations during contractions to phenylephrine (EC(50)=5*10(-8) mol/L). Relaxation after PGE(2) was absent in rings without endothelium and in rings from eNOS(-/-) mice and was abolished by N(G)-nitro-l-arginine methyl ester and the soluble guanylate cyclase inhibitor 1H(1,2,4)-oxadiazolo-[4,3-a]quinoxalin-1-one. In PGE(2)-relaxed aortic rings, the cGMP content increased significantly. PGE(2)-induced relaxations were abolished by the EP4 receptor antagonist AE3-208 (10(-8) mol/L) and mimicked by an EP4 agonist (AE1-329, 10(-7) mol/L) in the presence of endothelium and eNOS only. Relaxations were attenuated significantly in rings from EP4(-/-) mice but normal in EP2(-/-). Inhibitors of the cAMP-protein kinase A pathway attenuated, whereas the inhibitor of protein phosphatase 1C, calyculin (10(-8) mol/L), abolished the PGE(2)-mediated relaxation. In aortic rings, PGE(2) dephosphorylated eNOS at Thr(495). Chronically catheterized eNOS(-/-) mice were hypertensive (137+/-3.6 mm Hg, n=13, versus 101+/-3.9 mm Hg, n=9) and exhibited a lower sensitivity of blood pressure reduction in response to PGE(2) compared with wild-type mice. There was no difference in the blood pressure response to nifedipine. These findings show that PGE(2) elicits EP4 receptor-mediated, endothelium-dependent stimulation of eNOS activity by dephosphorylation at Thr(495) resulting in guanylyl cyclase-dependent vasorelaxation and accumulation of cGMP in aortic rings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17635857     DOI: 10.1161/HYPERTENSIONAHA.107.088948

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  47 in total

1.  A major role for the EP4 receptor in regulation of renin.

Authors:  Carie S Facemire; Mytrang Nguyen; Leigh Jania; William H Beierwaltes; Hyung-Suk Kim; Beverly H Koller; Thomas M Coffman
Journal:  Am J Physiol Renal Physiol       Date:  2011-08-10

2.  Enhanced pressor response to acute Ang II infusion in mice lacking membrane-associated prostaglandin E2 synthase-1.

Authors:  Dong-juan Zhang; Li-hong Chen; Ya-hua Zhang; Guang-rui Yang; Dou Dou; Yuan-sheng Gao; Xiao-yan Zhang; Xiao-mu Kong; Pan Zhao; Dan Pu; Ming-fen Wei; Matthew-D Breyer; You-fei Guan
Journal:  Acta Pharmacol Sin       Date:  2010-09-27       Impact factor: 6.150

3.  Cutaneous vascular and sweating responses to intradermal administration of prostaglandin E1 and E2 in young and older adults: a role for nitric oxide?

Authors:  Naoto Fujii; Maya Sarah Singh; Lyra Halili; Pierre Boulay; Ronald J Sigal; Glen P Kenny
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-04-13       Impact factor: 3.619

4.  Endothelial cell prostaglandin E2 receptor EP4 is essential for blood pressure homeostasis.

Authors:  Hu Xu; Bingying Fang; Shengnan Du; Sailun Wang; Qingwei Li; Xiao Jia; Chengzhen Bao; Lan Ye; Xue Sui; Lei Qian; Zhilin Luan; Guangrui Yang; Feng Zheng; Nanping Wang; Lihong Chen; Xiaoyan Zhang; Youfei Guan
Journal:  JCI Insight       Date:  2020-07-09

5.  PGE2 through the EP4 receptor controls smooth muscle gene expression patterns in the ductus arteriosus critical for remodeling at birth.

Authors:  Artiom Gruzdev; MyTrang Nguyen; Martina Kovarova; Beverly H Koller
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-02-11       Impact factor: 3.072

6.  Prostaglandin E-prostanoid4 receptor mediates angiotensin II-induced (pro)renin receptor expression in the rat renal medulla.

Authors:  Fei Wang; Xiaohan Lu; Kexin Peng; Yaomin Du; Shu-Feng Zhou; Aihua Zhang; Tianxin Yang
Journal:  Hypertension       Date:  2014-05-27       Impact factor: 10.190

7.  Rostral Ventrolateral Medulla EP3 Receptor Mediates the Sympathoexcitatory and Pressor Effects of Prostaglandin E2 in Conscious Rats.

Authors:  Samar Rezq; Abdel A Abdel-Rahman
Journal:  J Pharmacol Exp Ther       Date:  2016-08-29       Impact factor: 4.030

8.  Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunction.

Authors:  Joshua M Diamond; Tatiana Akimova; Altaf Kazi; Rupal J Shah; Edward Cantu; Rui Feng; Matthew H Levine; Steven M Kawut; Nuala J Meyer; James C Lee; Wayne W Hancock; Richard Aplenc; Lorraine B Ware; Scott M Palmer; Sangeeta Bhorade; Vibha N Lama; Ann Weinacker; Jonathan Orens; Keith Wille; Maria Crespo; David J Lederer; Selim Arcasoy; Ejigayehu Demissie; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2014-03-01       Impact factor: 21.405

9.  Inactivation of the E-prostanoid 3 receptor attenuates the angiotensin II pressor response via decreasing arterial contractility.

Authors:  Lihong Chen; Yifei Miao; Yahua Zhang; Dou Dou; Limei Liu; Xiaoyu Tian; Guangrui Yang; Dan Pu; Xiaoyan Zhang; Jihong Kang; Yuansheng Gao; Shiqiang Wang; Matthew D Breyer; Nanping Wang; Yi Zhu; Yu Huang; Richard M Breyer; Youfei Guan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-10-11       Impact factor: 8.311

10.  Indomethacin promotes nitric oxide function in the ductus arteriosus in the mouse.

Authors:  D Sodini; B Baragatti; S Barogi; V E Laubach; F Coceani
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.